Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Novartis Pharmaceuticals Corporation
FDA Inspection
•Novartis Pharmaceuticals Corporation•February 5, 2009

FDA Inspection 562113 - Novartis Pharmaceuticals Corporation - February 05, 2009

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Novartis Pharmaceuticals Corporation, with an inspection on February 5, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Novartis Pharmaceuticals Corporation
Inspection Date
February 5, 2009
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Open in Dashboard

ID · fbc3b680-4a0d-4b56-840d-4ccf86a24559

Violation Codes4
21 CFR 211.180(e)21 CFR 211.180(e)(2)21 CFR 211.194(a)(2)21 CFR 211.22(d)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.